The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP
Open accessAbstract
The FDA approval of emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis (PrEP) in 2012 has raised questions about the delivery of PrEP in a real-world setting. iPad-based questionnaires were given to providers at conferences in California and New York to assess knowledge, experience and attitudes regarding PrEP in HIV and non-HIV providers. HIV provider status was defined either by self-identification or by having greater than 5 years of HIV care experience. Knowledge scores were the sum of correct answers from five PrEP knowledge questions. Univariate analyses used t-test to compare knowledge scores and Fisher’s exact test for past or future PrEP prescription between HIV and non-HIV providers. Multivariable linear or logistic regression models were used to assess factors associated with the outcomes. Of 233 respondents, the mean age was 40 years, 59 % were White, 59 % were physicians and 52 % were HIV providers. In univariate analysis, mean PrEP knowledge scores (max 5) were significantly higher for HIV providers (2.8 versus 2.2; p < 0.001), age > 41 (mean 2.8 versus 2.3; p = 0.004), White race (2.7 versus 2.2; p = 0.026) and participants in the New York region (3.0 versus 2.3; p < 0.001). In a multivariable model of knowledge scores, all but age remained significant. Among 201 potential prescribers, the rate of prior PrEP prescription was higher among HIV providers than non-HIV providers (34 versus 9 %; p < 0.001) and by knowledge score, but the association with provider status was no longer significant in multivariable analysis that controlled for knowledge. Intent to prescribe PrEP in the future was high for all provider types (64 %) and was associated with knowledge scores in multivariable analysis. The most common concerns about PrEP (>40 % of providers) were drug toxicities, development of resistance and patient adherence to follow-up; 32 % identified risk compensation as a concern. HIV providers had significantly greater PrEP knowledge than non-HIV providers, but differences by provider type in past PrEP prescription were largely dependent on knowledge. Future PrEP prescription was also associated with knowledge, though all providers expressed greater future use. Education of potential PrEP providers will be a key component of successful PrEP implementation.ResumenLa aprobación de Emtricitabina/Fumarato de Disoproxilo de Tenofovir por la FDA para PrEP en 2012 ha originado preguntas acerca del suministro de profilaxis pre-exposición (PrEP) en un escenario real. Cuestionarios a través de dispositivo iPad fueron proporcionados a proveedores de salud especialistas en VIH y proveedores de salud en general durante conferencias en California y Nueva York para evaluar conocimiento, experiencia y actitudes en cuanto a PrEP. La categoría de proveedor de salud especialista en VIH fue definida por identificación propia o por tener más de cinco años de experiencia en el cuidado de VIH. Los marcadores de conocimiento fueron la suma de respuestas correctas a cinco preguntas de conocimiento sobre PrEP. El análisis univariado utilizó la prueba t-test para comparar los marcadores de conocimiento y la prueba exacta Fisher se utilizó para pasadas o futuras prescripciones médicas de PrEP entre proveedores de salud especialistas en VIH y proveedores de salud en general. Los modelos linear multivariable o de regresión logística fueron utilizados para evaluar factores asociados con los resultados. De 233 encuestados, la edad promedio fue 40 años, 59 % fueron raza Blanca, 59 % fueron médicos y 52 % fueron proveedores de salud especialistas en VIH. En análisis univariado, el promedio en el marcador de de conocimientos sobre PrEP (max 5) fue significativamente mayor para proveedores de salud especialistas en VIH (en un 2.8 versus 2.2; p<0.001), edad >41 (promedio 2.8 versus 2.3; p=0.004), raza blanca (2.7 versus 2.2; p=0.0.26) y los participantes de la region de Nueva York (3.0 versus 2.3; p<0.001). En el modelo multivariable de marcadores de conocimiento, todo excepto la edad permaneció significantivo. Entre 201 potenciales proveedores que prescribirán una receta médica para PrEP, el índice de haber prescrito con aterioridad fue mayor entre proveedores de salud especialistas en VIH que en los proveedores de salud en general (34 % versus 9 %; p<0.001) en cuanto a marcador de conocimiento, la asociacion de la categoría de los proveedores de salud no fue significantiva en el anáslisis multivariable que controló el conocimiento. Los planes de prescribir PrEP en un futuro fue mayor para los dos tipos de proveedores de salud (64 %) y estuvo asociada con los marcadores de conocmiento en el análisis multivariable. Las preocupaciones más communes en cuanto a PrEP (>40 % de los proveedores) fue la toxicidad del medicamento, desarrollo de Resistencia y la adherencia o apego de parte del paciente; 32 % identificaron a la compensación de riesgo como una preocupación. Proveedores de salud especialistas en VIH tuvieron un conocimiento de PrEP significativamente mayor que los proveedores de salud en general, pero las diferencias entre los tipos de proveedor en prescripciones médicas de PrEP anteriores fueron ampliamente dependientes del conocimiento. Prescripciones médicas de PrEP futuras fue asociado con conocimiento, sin embargo todos los proveedores expresaron una mayor utilización en el futuro. La educación sobre PrEP en proveedores de salud será un componente clave en el éxito de la implementación de PrEP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Self-citationAntiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110711 · Cited by 1,996
Cited by
Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review
Mayer, K. H., Agwu, A., & Malebranche, D. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01295-0 · Cited by 426
Self-citationCahill, S., Taylor, S. W., Elsesser, S. A., Mena, L., Hickson, D., & Mayer, K. H. (2017) · AIDS Care · doi:10.1080/09540121.2017.1300633 · Cited by 402
Self-citationCalabrese, S. K., & Underhill, K. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302816 · Cited by 313
Petroll, A. E., Walsh, J. L., Owczarzak, J. L., McAuliffe, T. L., Bogart, L. M., & Kelly, J. A. (2017) · AIDS and Behavior · doi:10.1007/s10461-016-1625-1 · Cited by 309
Applying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, Georgia
Kelley, C. F., Kahle, E., Siegler, A., Sanchez, T., del Rio, C., Sullivan, P. S., & Rosenberg, E. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ664 · Cited by 298
Metadata
- Authors
- The CCTG 598 Team, Blumenthal, J., Jain, S., Krakower, D., Sun, X., Young, J., Mayer, K., & Haubrich, R.
- Venue
- AIDS and Behavior
- Published
- 2015-01-24
- Volume
- 19
- Issue
- 5
- Pages
- 802-810
- ISSN
- 1090-7165 (ISSN-L)
- 1573-3254
- OpenAlex
- W2082494113
- Cited by
- 191
- References
- 3
- FWCI
- 12.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP. https://app.cochat.ai/papers/10.1007/s10461-015-0996-z
- The paper
- The CCTG 598 Team, Blumenthal, J., Jain, S., Krakower, D., Sun, X., Young, J., Mayer, K., & Haubrich, R. (2015). Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP. AIDS and Behavior. https://doi.org/10.1007/s10461-015-0996-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.